Kinetics of T-cell-based assays on cerebrospinal fluid and peripheral blood mononuclear cells in patients with tuberculous meningitis

Korean Journal of Internal Medicine

Volumn 29, Issue 6, 2014, Pages 793-799

  Park, Ki Ho ^a   Lee, Mi Suk ^a   Lee, Sang Oh ^b   Choi, Sang Ho ^b   Kim, Yang Soo ^b   Woo, Jun Hee ^b   Kang, Joong Koo ^b   Lee, Sang Ahm ^b   Kim, Sung Han ^b  

^a Kyung Hee University Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Cerebrospinal fluid; Enzyme linked immunosorbent assay; Meningitis; Tuberculosis

Indexed keywords

GAMMA INTERFERON; BIOLOGICAL MARKER; IFNG PROTEIN, HUMAN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID MONONUCLEAR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGY TEST KIT; LEUKOCYTE COUNT; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; SOUTH KOREA; T LYMPHOCYTE; TUBERCULOUS MENINGITIS; BLOOD; DRUG EFFECTS; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; KINETICS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PREDICTIVE VALUE; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL;

ADULT; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; KINETICS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; T-LYMPHOCYTES; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL;

EID: 84908508708     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2014.29.6.793     Document Type: Article

References (24)

1. Kim SH, Cho OH, Park SJ, et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis 2010;50:1349-1358.
2. Patel VB, Singh R, Connolly C, et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med 2010;182:569-577.
3. Kim SH, Chu K, Choi SJ, et al. Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Vaccine Immunol 2008;15:1356-1362.
4. Thomas MM, Hinks TS, Raghuraman S, et al. Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. Int J Tuberc Lung Dis 2008;12:651-657.
5. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004;38:754-756.
6. Aiken AM, Hill PC, Fox A, et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006;6:66.
7. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect 2009;58:197-204.
8. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008;12:1146-1152.
9. Dheda K, Pooran A, Pai M, et al. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect 2007;55:169-173.
10. Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 2010;10:803-812.
11. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662.
12. Kim SH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis. Arch Intern Med 2007;167:2255-2259.
13. Park KH, Cho OH, Ko GB, et al. Serial testing of T-SPOT. TB assays with anti-tuberculosis therapy in patients with extrapulmonay tuberculosis. Infect Chemother 2011;43:245-250.
14. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001;69:6554-6557.
15. Ulrichs T, Anding R, Kaufmann SH, Munk ME. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 2000;4:1181-1183.
16. Ferrand RA, Bothamley GH, Whelan A, Dockrell HM. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 2005;9:1034-1039.
17. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 2003;38:249-256.
18. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217-5225.
19. Lee SW, Lee CT, Yim JJ. Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis 2010;10:300.
20. Chee CB, KhinMar KW, Gan SH, et al. Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J 2010;36:355-361.
21. Cheng VC, Yam WC, Woo PC, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003;22:597-602.
22. Kim SH, Kim YS. Immunologic paradox in the diagnosis of tuberculous meningitis. Clin Vaccine Immunol 2009;16:1847-1849.
23. Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002;360:1287-1292.
24. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741-1751.